Baricitinib, Methotrexate as Monotherapy or Combination in the Treatment of Rheumatoid Arthritis - an Open Label Randomized Clinical Trial

NCT05827497 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Baricitinib 2 MG
DRUG: Methotrexate 25mg

Sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh